Showing results (21-30 of 37) with videos related to
Sort By:
Pageof 4
EMBO Molecular Medicine|February 22, 2021
Intraductal xenografts show lobular carcinoma cells rely on their own extracellular matrix and LOXL1George Sflomos, Laura Battista, Patrick Aouad, et al.Revue Medicale Suisse|January 11, 2019
[Oncology, what's new in 2018]Sofiya Latifyan, Artemisia Kakourou, Berna Ozdemir, et al.Nature Communications|June 6, 2022
Estrogen receptor positive breast cancers have patient specific hormone sensitivities and rely on progesterone receptorValentina Scabia, Ayyakkannu Ayyanan, Fabio De Martino, et al.Pharmaceutics|July 27, 2022
Population Pharmacokinetics of Palbociclib and Its Correlation with Clinical Efficacy and Safety in Patients with Advanced Breast CancerPerrine Courlet, Evelina Cardoso, Carole Bandiera, et al.Cancers|January 8, 2023
Adherence to the CDK 4/6 Inhibitor Palbociclib and Omission of Dose Management Supported by Pharmacometric Modelling as Part of the OpTAT StudyCarole Bandiera, Isabella Locatelli, Perrine Courlet, et al.Plos One|June 7, 2024
A pharmacist-led interprofessional medication adherence program improved adherence to oral anticancer therapies: The OpTAT randomized controlled trialCarole Bandiera, Evelina Cardoso, Isabella Locatelli, et al.Oncology Letters|June 23, 2020
Oncology during the COVID-19 pandemic: challenges, dilemmas and the psychosocial impact on cancer patientsKonstantinos Tsamakis, Maria Gavriatopoulou, Dimitrios Schizas, et al.Revue Medicale Suisse|January 22, 2020
[Advances in Oncology 2019]Anastasia Vernadou, Nabila Ferahta, Nuria Mederos, et al.Revue Medicale Suisse|January 28, 2021
[2020 oncology update]Giovanni Dei Tos, Ilianna Galli Vareia, Alexandre Huber, et al.Journal of Cancer Research and Clinical Oncology|May 29, 2025
Retrospective comprehensive analysis of regional lymph node recurrence in breast cancer patients (REASON study)Aikaterini Liapi, Veronica Aedo-Lopez, Wendy Jeanneret-Sozzi, et al.Pageof 4